| Deal type | Spread component | Risk profile |
|---|---|---|
| All-cash deal | Fixed cash price; spread = ($deal price - target price) / target price | Pure deal-completion risk; cleaner to model |
| All-stock deal (fixed ratio) | Exchange ratio determines value; spread depends on acquirer share price | Add long-short pair risk (acquirer + target price correlation) |
| Cash-and-stock collar | Floor/ceiling on stock portion; complex value calculation | Multiple risk vectors -- highest skill threshold |
| Hostile / contested | Wider spread reflecting deal uncertainty | Antitrust + shareholder-approval + financing risk concentrated |
| Reverse Morris Trust / inversions | Tax-driven structure; deal value depends on tax outcome | Tax-rule-change risk + spinoff-merger combined complexity |
Antitrust risk is the single biggest unpriced spread component in 2024-2026 deals. The FTC and DOJ under recent leadership have challenged more deals than in the prior decade (visa-Plaid, Microsoft-Activision, JetBlue-Spirit). Spreads in pharma, big-tech, and concentrated-industry deals reflect this uncertainty even when both boards have approved. Reading the HSR antitrust filings is the merger-arb edge most retail investors skip.
Retail merger arb has STRUCTURAL DISADVANTAGES vs institutional arbs. Pros: brokerage cost is similar at retail vs institutional scale on liquid names. Cons: (1) institutional arbs read SEC filings within minutes; retail reads them next day; (2) merger-arb funds carry deal-broken positions across hundreds of deals so single-deal failures don't impair the portfolio -- retail concentrating in one deal eats the full downside; (3) shorting the acquirer in stock deals requires margin + locate -- not always available at retail.
Merger arb captures the deal spread between announcement and closing. The spread compensates for time value + residual deal-fail risk. Break fees and antitrust filings are the substrate signals to read. Retail can play arb on liquid deals but should diversify across multiple deals to absorb single-deal failures.
Sit with the ideas.
An announced cash-and-stock merger trades at a 4% deal spread two months before expected closing. Antitrust filings are routine, both boards have approved, financing is committed. What is the dominant driver of that 4% spread?